Home › Companies › CARDIFF ONCOLOGY INC. › 2024-2025
Compiled from SEC Form N-PX filings and CARDIFF ONCOLOGY INC.’s Form 8-K, filed 2025-06-26 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Proxy season: 2024-2025 2025-2026
Explore CARDIFF ONCOLOGY INC. in the interactive database Compare manager voting policies
These tallies are CARDIFF ONCOLOGY INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-26 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Mark Erlander, Ph.D. | 20,509,615 | 0 | 1,488,425 | -- | 16,651,851 | Majority: yes |
| Elect Director: Dr. Rodney Markin | 20,730,735 | 0 | 1,267,304 | -- | 16,651,852 | Majority: yes |
| Elect Director: Dr. James O. Armitage | 20,521,597 | 0 | 1,476,443 | -- | 16,651,851 | Majority: yes |
| Elect Director: Lale White | 20,380,890 | 0 | 1,617,150 | -- | 16,651,851 | Majority: yes |
| Elect Director: Gary W. Pace, Ph.D. | 21,230,105 | 0 | 767,935 | -- | 16,651,851 | Majority: yes |
| Elect Director: Mani Mohindru, Ph.D. | 20,590,042 | 0 | 1,407,999 | -- | 16,651,850 | Majority: yes |
| Elect Director: Renee P. Tannenbaum, Pharm.D. | 20,560,088 | 0 | 1,437,951 | -- | 16,651,852 | Majority: yes |
| Proposal 4. The advisory vote on the compensation of the Company's named executive officers was approved by the stockholders by the votes set forth in the table below: | 18,881,817 | 2,576,465 | 539,755 | -- | 16,651,854 | Majority: yes |
Source: CARDIFF ONCOLOGY INC., Form 8-K, filed with the SEC on 2025-06-26 — read the filing on EDGAR.
Each item below shows how the 105 asset managers that disclosed a CARDIFF ONCOLOGY INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CARDIFF ONCOLOGY INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 8 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
CARDIFF ONCOLOGY INC.’s own tally for this item (“Proposal 4. The advisory vote on the compensation of the Company's named executive officers was approved by the stockholders by the votes set forth in the table below:”): 18,881,817 for, 2,576,465 against, per its Form 8-K filed 2025-06-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,525,854 outstanding shares: 28% for, 4% against (32% of the company cast a for/against vote).
The 105 asset managers below cast 99.4% of the shares they voted on this item FOR (10,342,962 for, 62,052 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,661,822 | 0 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 1,656,168 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 1,483,169 | 0 | 0 | 0 | For |
| Vanguard | 1,345,028 | 0 | 0 | 0 | For |
| Commodore Capital LP | 1,250,000 | 0 | 0 | 0 | For |
| State Street | 413,625 | 1,916 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 377,714 | 0 | 0 | 0 | For |
| Northern Trust | 261,688 | 0 | 0 | 0 | For |
| Citadel | 218,774 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 176,039 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 150,000 | 0 | 0 | 0 | For |
| Point72 | 119,447 | 0 | 0 | 0 | For |
| Nuveen | 101,391 | 0 | 0 | 0 | For |
| TIAA | 101,391 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 101,046 | 0 | 0 | 0 | For |
| Fidelity | 56,020 | 0 | 0 | 0 | For |
| CAPSTONE INVESTMENT ADVISORS, LLC | 51,190 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 47,000 | 0 | 0 | 0 | For |
| RBC Capital Markets, LLC | 46,865 | 0 | 0 | 0 | For |
| Equitable | 24,579 | 22,007 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| AQR | 42,568 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 40,093 | 0 | 0 | 0 | For |
| Charles Schwab | 33,348 | 0 | 0 | 0 | For |
| Two Sigma | 32,232 | 0 | 0 | 0 | For |
Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.
Combines 4 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
CARDIFF ONCOLOGY INC.’s own tally for this item (“Elect Director: Gary W. Pace, Ph.D.”): 21,230,105 for, 0 against, per its Form 8-K filed 2025-06-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,525,854 outstanding shares: 32% for, 0% against (32% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (2,707,076 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,297,156 | 0 | 0 | 0 | For |
| BlackRock | 942,687 | 0 | 0 | 0 | For |
| TIAA | 101,391 | 0 | 0 | 0 | For |
| Fidelity | 46,860 | 0 | 0 | 0 | For |
| Equitable | 46,586 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 30,533 | 0 | 0 | 0 | For |
| Northern Trust | 28,548 | 0 | 0 | 0 | For |
| Pacific Life | 25,877 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,376 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,220 | 0 | 0 | 0 | For |
| AQR | 21,208 | 0 | 0 | 0 | For |
| Charles Schwab | 16,674 | 0 | 0 | 0 | For |
| Voya | 9,910 | 0 | 0 | 0 | For |
| Global X | 9,542 | 0 | 0 | 0 | For |
| Victory Capital | 6,297 | 0 | 0 | 0 | For |
| Brighthouse | 4,970 | 0 | 0 | 0 | For |
| Nationwide | 4,875 | 0 | 0 | 0 | For |
| DWS | 4,196 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,900 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 3,838 | 0 | Abstain |
| John Hancock | 3,079 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,917 | 0 | 0 | 0 | For |
| State Street | 2,297 | 0 | 0 | 0 | For |
| ProShares | 2,080 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 4 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
CARDIFF ONCOLOGY INC.’s own tally for this item (“Elect Director: Dr. James O. Armitage”): 20,521,597 for, 0 against, per its Form 8-K filed 2025-06-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,525,854 outstanding shares: 31% for, 0% against (31% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (2,710,914 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,297,156 | 0 | 0 | 0 | For |
| BlackRock | 942,687 | 0 | 0 | 0 | For |
| TIAA | 101,391 | 0 | 0 | 0 | For |
| Fidelity | 46,860 | 0 | 0 | 0 | For |
| Equitable | 46,586 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 30,533 | 0 | 0 | 0 | For |
| Northern Trust | 28,548 | 0 | 0 | 0 | For |
| Pacific Life | 25,877 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,376 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,220 | 0 | 0 | 0 | For |
| AQR | 21,208 | 0 | 0 | 0 | For |
| Charles Schwab | 16,674 | 0 | 0 | 0 | For |
| Voya | 9,910 | 0 | 0 | 0 | For |
| Global X | 9,542 | 0 | 0 | 0 | For |
| Victory Capital | 6,297 | 0 | 0 | 0 | For |
| Brighthouse | 4,970 | 0 | 0 | 0 | For |
| Nationwide | 4,875 | 0 | 0 | 0 | For |
| DWS | 4,196 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,900 | 0 | 0 | 0 | For |
| Calvert | 3,838 | 0 | 0 | 0 | For |
| John Hancock | 3,079 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,917 | 0 | 0 | 0 | For |
| State Street | 2,297 | 0 | 0 | 0 | For |
| ProShares | 2,080 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 5 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
CARDIFF ONCOLOGY INC.’s own tally for this item (“Elect Director: Lale White”): 20,380,890 for, 0 against, per its Form 8-K filed 2025-06-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,525,854 outstanding shares: 31% for, 0% against (31% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (2,710,914 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,297,156 | 0 | 0 | 0 | For |
| BlackRock | 942,687 | 0 | 0 | 0 | For |
| TIAA | 101,391 | 0 | 0 | 0 | For |
| Fidelity | 46,860 | 0 | 0 | 0 | For |
| Equitable | 46,586 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 30,533 | 0 | 0 | 0 | For |
| Northern Trust | 28,548 | 0 | 0 | 0 | For |
| Pacific Life | 25,877 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,376 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,220 | 0 | 0 | 0 | For |
| AQR | 21,208 | 0 | 0 | 0 | For |
| Charles Schwab | 16,674 | 0 | 0 | 0 | For |
| Voya | 9,910 | 0 | 0 | 0 | For |
| Global X | 9,542 | 0 | 0 | 0 | For |
| Victory Capital | 6,297 | 0 | 0 | 0 | For |
| Brighthouse | 4,970 | 0 | 0 | 0 | For |
| Nationwide | 4,875 | 0 | 0 | 0 | For |
| DWS | 4,196 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,900 | 0 | 0 | 0 | For |
| Calvert | 3,838 | 0 | 0 | 0 | For |
| John Hancock | 3,079 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,917 | 0 | 0 | 0 | For |
| State Street | 2,297 | 0 | 0 | 0 | For |
| ProShares | 2,080 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 4 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
CARDIFF ONCOLOGY INC.’s own tally for this item (“Elect Director: Mani Mohindru, Ph.D.”): 20,590,042 for, 0 against, per its Form 8-K filed 2025-06-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,525,854 outstanding shares: 31% for, 0% against (31% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (2,710,914 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,297,156 | 0 | 0 | 0 | For |
| BlackRock | 942,687 | 0 | 0 | 0 | For |
| TIAA | 101,391 | 0 | 0 | 0 | For |
| Fidelity | 46,860 | 0 | 0 | 0 | For |
| Equitable | 46,586 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 30,533 | 0 | 0 | 0 | For |
| Northern Trust | 28,548 | 0 | 0 | 0 | For |
| Pacific Life | 25,877 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,376 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,220 | 0 | 0 | 0 | For |
| AQR | 21,208 | 0 | 0 | 0 | For |
| Charles Schwab | 16,674 | 0 | 0 | 0 | For |
| Voya | 9,910 | 0 | 0 | 0 | For |
| Global X | 9,542 | 0 | 0 | 0 | For |
| Victory Capital | 6,297 | 0 | 0 | 0 | For |
| Brighthouse | 4,970 | 0 | 0 | 0 | For |
| Nationwide | 4,875 | 0 | 0 | 0 | For |
| DWS | 4,196 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,900 | 0 | 0 | 0 | For |
| Calvert | 3,838 | 0 | 0 | 0 | For |
| John Hancock | 3,079 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,917 | 0 | 0 | 0 | For |
| State Street | 2,297 | 0 | 0 | 0 | For |
| ProShares | 2,080 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 4 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
CARDIFF ONCOLOGY INC.’s own tally for this item (“Elect Director: Mark Erlander, Ph.D.”): 20,509,615 for, 0 against, per its Form 8-K filed 2025-06-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,525,854 outstanding shares: 31% for, 0% against (31% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (2,710,914 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,297,156 | 0 | 0 | 0 | For |
| BlackRock | 942,687 | 0 | 0 | 0 | For |
| TIAA | 101,391 | 0 | 0 | 0 | For |
| Fidelity | 46,860 | 0 | 0 | 0 | For |
| Equitable | 46,586 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 30,533 | 0 | 0 | 0 | For |
| Northern Trust | 28,548 | 0 | 0 | 0 | For |
| Pacific Life | 25,877 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,376 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,220 | 0 | 0 | 0 | For |
| AQR | 21,208 | 0 | 0 | 0 | For |
| Charles Schwab | 16,674 | 0 | 0 | 0 | For |
| Voya | 9,910 | 0 | 0 | 0 | For |
| Global X | 9,542 | 0 | 0 | 0 | For |
| Victory Capital | 6,297 | 0 | 0 | 0 | For |
| Brighthouse | 4,970 | 0 | 0 | 0 | For |
| Nationwide | 4,875 | 0 | 0 | 0 | For |
| DWS | 4,196 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,900 | 0 | 0 | 0 | For |
| Calvert | 3,838 | 0 | 0 | 0 | For |
| John Hancock | 3,079 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,917 | 0 | 0 | 0 | For |
| State Street | 2,297 | 0 | 0 | 0 | For |
| ProShares | 2,080 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 4 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
CARDIFF ONCOLOGY INC.’s own tally for this item (“Elect Director: Renee P. Tannenbaum, Pharm.D.”): 20,560,088 for, 0 against, per its Form 8-K filed 2025-06-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,525,854 outstanding shares: 31% for, 0% against (31% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (2,710,914 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,297,156 | 0 | 0 | 0 | For |
| BlackRock | 942,687 | 0 | 0 | 0 | For |
| TIAA | 101,391 | 0 | 0 | 0 | For |
| Fidelity | 46,860 | 0 | 0 | 0 | For |
| Equitable | 46,586 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 30,533 | 0 | 0 | 0 | For |
| Northern Trust | 28,548 | 0 | 0 | 0 | For |
| Pacific Life | 25,877 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,376 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,220 | 0 | 0 | 0 | For |
| AQR | 21,208 | 0 | 0 | 0 | For |
| Charles Schwab | 16,674 | 0 | 0 | 0 | For |
| Voya | 9,910 | 0 | 0 | 0 | For |
| Global X | 9,542 | 0 | 0 | 0 | For |
| Victory Capital | 6,297 | 0 | 0 | 0 | For |
| Brighthouse | 4,970 | 0 | 0 | 0 | For |
| Nationwide | 4,875 | 0 | 0 | 0 | For |
| DWS | 4,196 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,900 | 0 | 0 | 0 | For |
| Calvert | 3,838 | 0 | 0 | 0 | For |
| John Hancock | 3,079 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,917 | 0 | 0 | 0 | For |
| State Street | 2,297 | 0 | 0 | 0 | For |
| ProShares | 2,080 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
Combines 4 wordings of this item as funds reported it.
100% Majority: yes · of votes cast
CARDIFF ONCOLOGY INC.’s own tally for this item (“Elect Director: Dr. Rodney Markin”): 20,730,735 for, 0 against, per its Form 8-K filed 2025-06-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,525,854 outstanding shares: 31% for, 0% against (31% of the company cast a for/against vote).
The 32 asset managers below cast 100% of the shares they voted on this item FOR (2,706,218 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,297,156 | 0 | 0 | 0 | For |
| BlackRock | 942,687 | 0 | 0 | 0 | For |
| TIAA | 101,391 | 0 | 0 | 0 | For |
| Fidelity | 46,860 | 0 | 0 | 0 | For |
| Equitable | 46,586 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 30,533 | 0 | 0 | 0 | For |
| Northern Trust | 28,548 | 0 | 0 | 0 | For |
| Pacific Life | 25,877 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,376 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,220 | 0 | 0 | 0 | For |
| AQR | 21,208 | 0 | 0 | 0 | For |
| Charles Schwab | 16,674 | 0 | 0 | 0 | For |
| Voya | 9,910 | 0 | 0 | 0 | For |
| Global X | 9,542 | 0 | 0 | 0 | For |
| Victory Capital | 6,297 | 0 | 0 | 0 | For |
| Brighthouse | 4,970 | 0 | 0 | 0 | For |
| Nationwide | 4,875 | 0 | 0 | 0 | For |
| DWS | 4,196 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,900 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 3,838 | 0 | Abstain |
| John Hancock | 3,079 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,917 | 0 | 0 | 0 | For |
| State Street | 2,297 | 0 | 0 | 0 | For |
| ProShares | 2,080 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
98% fund support · no official result
The 32 asset managers below cast 98% of the shares they voted on this item FOR (2,652,242 for, 55,230 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,297,156 | 0 | 0 | 0 | For |
| BlackRock | 942,687 | 0 | 0 | 0 | For |
| TIAA | 101,391 | 0 | 0 | 0 | For |
| Fidelity | 43,679 | 3,181 | 0 | 0 | For |
| Equitable | 46,586 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 44,100 | 0 | 0 | Against |
| AIG/SunAmerica | 30,533 | 0 | 0 | 0 | For |
| Northern Trust | 28,548 | 0 | 0 | 0 | For |
| Pacific Life | 25,877 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,376 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,220 | 0 | 0 | 0 | For |
| AQR | 21,208 | 0 | 0 | 0 | For |
| Charles Schwab | 16,674 | 0 | 0 | 0 | For |
| Voya | 9,910 | 0 | 0 | 0 | For |
| Global X | 9,542 | 0 | 0 | 0 | For |
| Victory Capital | 6,297 | 0 | 0 | 0 | For |
| Brighthouse | 4,970 | 0 | 0 | 0 | For |
| DWS | 4,196 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,900 | 0 | 0 | 0 | For |
| Calvert | 0 | 3,838 | 0 | 0 | Against |
| John Hancock | 3,079 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,917 | 0 | 0 | 0 | For |
| State Street | 0 | 2,297 | 0 | 0 | Against |
| ProShares | 2,080 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 0 | 1,600 | 0 | 0 | Against |
Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.
100% fund support · no official result
The 25 asset managers below cast 100% of the shares they voted on this item FOR (1,688,036 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,297,156 | 0 | 0 | 0 | For |
| TIAA | 101,391 | 0 | 0 | 0 | For |
| Fidelity | 46,860 | 0 | 0 | 0 | For |
| Equitable | 46,586 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,100 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 30,533 | 0 | 0 | 0 | For |
| Northern Trust | 28,548 | 0 | 0 | 0 | For |
| Pacific Life | 25,877 | 0 | 0 | 0 | For |
| AQR | 21,208 | 0 | 0 | 0 | For |
| Voya | 9,910 | 0 | 0 | 0 | For |
| Victory Capital | 6,297 | 0 | 0 | 0 | For |
| Brighthouse | 4,970 | 0 | 0 | 0 | For |
| DWS | 4,196 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 3,900 | 0 | 0 | 0 | For |
| Calvert | 3,838 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,917 | 0 | 0 | 0 | For |
| State Street | 2,297 | 0 | 0 | 0 | For |
| ProShares | 2,080 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,600 | 0 | 0 | 0 | For |
| Nationwide | 1,433 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,190 | 0 | 0 | 0 | For |
| Guggenheim | 473 | 0 | 0 | 0 | For |
| Goldman Sachs | 462 | 0 | 0 | 0 | For |
| American Century | 136 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 78 | 0 | 0 | 0 | For |
100% fund support · no official result
The 7 asset managers below cast 100% of the shares they voted on this item FOR (1,019,436 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 942,687 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 25,376 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,220 | 0 | 0 | 0 | For |
| Charles Schwab | 16,674 | 0 | 0 | 0 | For |
| Global X | 9,542 | 0 | 0 | 0 | For |
| John Hancock | 3,079 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 858 | 0 | 0 | 0 | For |
Ranked by the number of CARDIFF ONCOLOGY INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 66,525,854 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.50% |
| 2 | BLAIR WILLIAM & CO/IL | 2.49% |
| 3 | Laurion Capital Management LP | 2.23% |
| 4 | Vanguard | 2.02% |
| 5 | Commodore Capital LP | 1.88% |
| 6 | State Street | 0.62% |
| 7 | JACOBS LEVY EQUITY MANAGEMENT, INC | 0.57% |
| 8 | Northern Trust | 0.39% |
| 9 | Citadel | 0.33% |
| 10 | MELLON INVESTMENTS Corp | 0.26% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Commodore Capital LP & Commodore Capital Master LP | 8.09% | DEF14A |
| BlackRock | 5.78% | 13F |
| Vanguard Group | 4.68% | 13F |
| Pfizer Inc. 13-5315170 | 3.63% | 13G |
| Mark Erlander, Ph.D. | 2.35% | DEF14A |
| Geode Capital | 2.10% | 13F |
| Gary W. Pace, Ph.D. | 1.81% | DEF14A |
| State Street | 1.41% | 13F |
| Citadel Advisors | 1.29% | 13F |
| James Levine | 1.15% | DEF14A |
Percentages above are of 66,525,854 shares outstanding, as reported by CARDIFF ONCOLOGY INC. on its Form 10-Q dated 2025-05-01 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CARDIFF ONCOLOGY INC.’s 10-Q dated 2025-05-01. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At CARDIFF ONCOLOGY INC.'s shareholder meeting held 2025-06-26, in the 2024-2025 proxy season, 105 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,001 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Proposal to approve, on an advisory basis, the compensation of the Company's named executive… — FOR was 88% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CARDIFF ONCOLOGY INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-26.
CARDIFF ONCOLOGY INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.